Evidence map›Paper›PMID 33091216›Full record

ArticleFEBS open bio2020

Immobilization of the extracellular recombinant Lucky9 xylanase from Bacillus subtilis enhances activity at high temperature and pH.

Sai-Sai Ding, Jin-Peng Zhu, Yang Wang, Bin Wu, Zongpei Zhao

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sai-Sai DingSchool of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang, China.
Jin-Peng ZhuSchool of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang, China.
Yang WangSchool of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang, China.
Bin WuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Zongpei ZhaoSchool of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang, China.ORCID 0000-0002-8814-4310
Jiangsu University of Science and Technology · CNNanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the paper industry, chlorine is often used to treat the pulp for bleaching. After pulping, a large amount of xylan is present in the fiber. Xylanase can be used to degrade xylan in an eco-friendly process called biobleaching, which can help minimize the usage of chlorine in the delignification process. However, a bottleneck in the adoption of biobleaching is the cost of xylanase and the requirement that xylanase be active and stable at extreme conditions. Here, we investigated whether using sodium alginate beads to immobilize an extracellular xylanase from Bacillus subtilis (Lucky9) can reduce the potential cost of enzyme usage. The optimal pH and the activity of the immobilized enzyme were increased at optimal temperature compared with the free enzyme. In addition, immobilized xylanase was shown to be more stable than free xylanase. The results of this study suggest that the immobilized xylanase has potential applications in the biobleaching industry.

Indexed as

Bacillus subtilisEndo-1,4-beta XylanasesEnzymes, ImmobilizedHydrogen-Ion ConcentrationTemperatureXylansEndo-1,4-beta XylanasesEnzymes, ImmobilizedXylansalkali tolerancebiobleachingimmobilizationsodium alginatethermostablexylanase

Identifiers

PMID33091216
PMCPMC7714079
OpenAlexW3093575796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.